id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-318593-ni84gzg5	Wolf, Jayanthi	Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens	2020-06-15		.txt	text/plain	4095	158	32	This report outlines the main lessons learned by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (MSD) during development of an Ebola Zaire vaccine (ERVEBO®) and looks ahead to critical lessons beyond vaccine development. These vaccine candidates were not taken into clinical development prior to the West African outbreak for several reasons, which included the inability to demonstrate clinical efficacy in the absence of an ongoing outbreak and lack of interest by the public health and vaccine development community to invest in the lengthy and costly process of vaccine development without a clear demand for an Ebola vaccine 2 .	cache/cord-318593-ni84gzg5.txt	txt/cord-318593-ni84gzg5.txt
